{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:42:11Z","timestamp":1793954531418,"version":"4.8.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review provides a framework for understanding inflammatory eye disease diagnosis, differential diagnosis, and management for rheumatologists. Uveitis, scleritis, episcleritis, peripheral ulcerative keratitis, and orbital inflammation are all discussed. The goal is to facilitate the development of approaches to inflammatory eye diseases that will help rheumatologists co-manage these patients with eye care providers specializing in ocular inflammation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In recent years, studies have aimed to advance biologic treatments and define standard-of-care therapy. Inflammatory eye diseases are highly heterogeneous and often rare, which poses significant challenges to their research and the interpretation of existing data. To date, glucocorticoids, mycophenolate, methotrexate, and TNF inhibitors remain the mainstay of treatment options for many of these diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Patients with inflammatory eye diseases require multidisciplinary care for best outcomes, frequently including rheumatologists. Understanding the differentials, diagnostics, and treatment are essential to preserving vision in these patients. The diverse nature of the disease processes within this field requires focusing on specific disease phenotypes and endotypes in research and clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000933","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T17:17:59Z","timestamp":1679419079000},"page":"201-212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Inflammatory eye disease for rheumatologists"],"prefix":"10.1097","volume":"35","author":[{"given":"Kelly","family":"Corbitt","sequence":"first","affiliation":[{"name":"New York University Grossman School of Medicine, Department of Medicine, Division of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nowatzky","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine, Department of Medicine, Division of Rheumatology"},{"name":"New York University Grossman School of Medicine, Department of Medicine, Division of Rheumatology, NYU Langone Beh\u00e7et's Disease Program, NYU Ocular Rheumatology Program"},{"name":"New York University Grossman School of Medicine, Department of Pathology, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijid.2020.09.1485","article-title":"Endogenous endophthalmitis in Klebsiella pneumoniae pyogenic liver abscess: systemic review and meta-analysis","volume":"101","author":"Hussain","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R4-20250526","first-page":"702","article-title":"The eye and rheumatic diseases","author":"Rosenbaum","year":"2021","journal-title":"Firestein & Kelley's textbook of rheumatology"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","article-title":"Sarcoidosis and uveitis","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of uveitides","volume":"156","author":"Jabs","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/OPTH.S180580","article-title":"Macular edema associated with noninfectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges","volume":"13","author":"Massa","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.semarthrit.2011.10.006","article-title":"Patients with retinal vasculitis rarely suffer from systemic vasculitis","volume":"41","author":"Rosenbaum","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.survophthal.2016.12.008","article-title":"Viral posterior uveitis","volume":"62","author":"Lee","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ICU.0000000000000522","article-title":"Ocular manifestations of bartonellosis","volume":"29","author":"Mabra","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3129\/i09-019","article-title":"Ocular involvement in brucellosis","volume":"44","author":"Sungur","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.survophthal.2021.06.003","article-title":"Ocular syphilis","volume":"67","author":"Furtado","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/OPTH.S65254","article-title":"Ocular tuberculosis: current perspectives","volume":"9","author":"Shakarchi","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R15-20250526","first-page":"792","article-title":"Characterization of uveitis associated with spondyloarthritis","volume":"16","author":"Rosenbaum","year":"1989","journal-title":"J Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ophtha.2016.03.010","article-title":"Description and prevalence of spondyloarthritis in patients with anterior uveitis: the SENTINEL Interdisciplinary Collaborative Project","volume":"123","author":"Juanola","year":"2016","journal-title":"Ophthalmology"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"m4979","DOI":"10.1136\/bmj.m4979","article-title":"Uveitis for the nonophthalmologist","volume":"372","author":"Burkholder","year":"2021","journal-title":"BMJ"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","article-title":"Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases","volume":"111","author":"Monnet","year":"2004","journal-title":"Ophthalmology"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9394(02)01709-9","article-title":"Multifocal choroiditis in patients with familial juvenie systemic granulomatosis","volume":"134","author":"Latkany","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09273948.2015.1094095","article-title":"Ocular Behcet's disease: changing patterns over time, complications and long-term visual prognosis","volume":"25","author":"Accorinti","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2009.07.025","article-title":"Hypopyon in patients with uveitis","volume":"117","author":"Zaidi","year":"2010","journal-title":"Ophthalmology"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0039-6257(01)00231-4","article-title":"Hypopyon uveitis","volume":"46","author":"Ramsay","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.2147\/OPTH.S287298","article-title":"Pattern of uveitis associated with Behcet's disease in an Egyptian cohort","volume":"14","author":"Abd El Latif","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0974-9233.58425","article-title":"Behcet's uveitis","volume":"16","author":"Tugal-Tutkun","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/09273948.2022.2026413","article-title":"Clinical features and outcomes of tubulointerstitial nephritis and uveitis syndrome in spain and portugal: the IBERTINU Project","volume":"31","author":"Giralt","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R27-20250526","first-page":"4586532","article-title":"Clinical and genetic features of tubulointerstitial nephritis and uveitis syndrome with long-term follow-up","author":"Kanno","year":"2018","journal-title":"J Ophthalmol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0161-6420(97)30361-3","article-title":"Scleritis-associated uveitis","volume":"104","author":"Sainz de la Maza","year":"1997","journal-title":"Ophthalmology"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/09273948.2011.619295","article-title":"HLA-A29 and birdshot chorioretinopathy","volume":"19","author":"Br\u00e9zin","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ajo.2021.03.036","article-title":"Classification criteria for Vogt-Koyanagi-Harada Disease","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0161-6420(00)00499-1","article-title":"Uveitis masquerade syndromes","volume":"108","author":"Rothova","year":"2001","journal-title":"Ophthalmology"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajo.2013.11.002","article-title":"Neoplastic masquerade syndromes among uveitis patients","volume":"157","author":"Grange","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/IAE.0000000000003171","article-title":"Causes and clinical manifestations of masquerade syndromes in intraocular inflammation","volume":"41","author":"Rothova","year":"2021","journal-title":"Retina"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2021.12.018","article-title":"Clinical manifestations and implications of nonneoplastic uveitis masquerade syndrome","volume":"238","author":"Hsu","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamental Of Care UveitiS (FOCUS) initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of antitumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Behcet's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R39-20250526","first-page":"1","article-title":"Mycophenolate versus methotrexate in noninfectious ocular inflammatory disease: a systemic review and meta-analysis","volume":"24","author":"Karam","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"e001161","DOI":"10.1136\/rmdopen-2019-001161","article-title":"The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW","volume":"6","author":"van der Horst-Bruinsma","year":"2020","journal-title":"RMD Open"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/keaa595","article-title":"Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis","volume":"60","author":"Maccora","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"(7\u20138)","key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1080\/09273948.2020.1749857","article-title":"Escalation to weekly adalimumab for the treatment of ocular inflammation","volume":"29","author":"Liberman","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.semarthrit.2020.05.017","article-title":"Effectiveness of tocilizumab in Behcet's disease: a systemic literature review","volume":"50","author":"Akiyama","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09273948.2020.1817501","article-title":"Tocilizumab employment in the treatment of resistant juvenie idiopathic arthritis associated uveitis","volume":"29","author":"Maleki","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R45-20250526","first-page":"2324400","article-title":"Role of Janus Kinase (JAK) inhibitor in autoimmune ocular inflammation: a systemic review","author":"Wen","year":"2021","journal-title":"J Immunol Res"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12348-021-00252-4","article-title":"Rituximab for noninfectious uveitis and scleritis","volume":"11","author":"Ng","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2020.06.038","article-title":"Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior, or panuveitis followed up to 10\u200ayears after randomization to fluocinolone acetonide implant or systemic therapy","volume":"219","author":"Kempen","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/jcm10102118","article-title":"Rheumatoid arthritis associated episcleritis and scleritis: an update on treatment perspectives","volume":"10","author":"Promelle","year":"2021","journal-title":"J Clin Med"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12348-021-00269-9","article-title":"Choroidal involvement in noninfectious posterior scleritis","volume":"11","author":"Vermeirsch","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11926-020-0885-y","article-title":"Noninfectious autoimmune scleritis: recognition, systemic associations, and therapy","volume":"22","author":"Nevares","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/09273948.2021.1966050","article-title":"Clinical relevance of autoantibodies and inflammatory parameters in noninfectious scleritis","volume":"30","author":"Vergouwen","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajo.2019.03.024","article-title":"Remission of noninfectious anterior scleritis: incience and predictive factors","volume":"223","author":"Kempen","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"101100","DOI":"10.1016\/j.ajoc.2021.101100","article-title":"Scleritis and sclerokeratitis associated with IgA vasculitis: a case series","volume":"22","author":"Hernanz","year":"2021","journal-title":"AM J Ophthalmol Case Rep"},{"key":"R54-20250526","first-page":"25158414211070879","article-title":"Management of noninfectious scleritis","volume":"14","author":"Abdel-Aty","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"252","DOI":"10.18502\/jovr.v17i2.10797","article-title":"Peripheral ulcerative keratitis: a review","volume":"17","author":"Hassanpour","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ceo.13709","article-title":"Ocular complications and mortality in peripheral ulcertive keratitis and necrotizing scleritis: The role of systemic immunosuppression","volume":"48","author":"Ogra","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/ICU.0000000000000517","article-title":"Ocular cicatricial pemphigoid","volume":"29","author":"Wang","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Vernereol"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"915205","DOI":"10.3389\/fimmu.2022.915205","article-title":"Rituximab therapy for mucous membrane pemphigoid: a retrospective monocentric study with long-term follow-up in 109 patients","volume":"13","author":"Bohelay","year":"2022","journal-title":"Front Immunol"},{"key":"R60-20250526","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100885","article-title":"Nonspecific orbital inflammation: current understanding and unmet needs","author":"Lee","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2021.04.024","article-title":"Teprotumumab: interpreting the clinical trials in context of thyroid eye disease pathogenesis and current therapies","volume":"128","author":"Winn","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:19:30Z","timestamp":1748294370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000933","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}